Dapagliflozin has No Protective Effect on Experimental Pulmonary Arterial Hypertension and Pulmonary Trunk Banding Rat Models

Dapagliflozin has No Protective Effect on Experimental Pulmonary Arterial Hypertension and Pulmonary Trunk Banding Rat Models

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a novel class of hypoglycemic drugs, show excellent cardiovascular benefits, and have further improved heart failure outcomes, significantly reducing cardiovascular and all-cause mortality irrespective of diabetes status. However, the efficacy of SG...

Full description

Bibliographic Details
Main Authors:	Huayang Li, Yitao Zhang, Shunjun Wang, Yuan Yue, Quan Liu, Suiqing Huang, Huajing Peng, Yi Zhang, Weijie Zeng, Zhongkai Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Pharmacology
Subjects:	pulmonary trunk banding pulmonary vascular remodeling right ventricular dysfunction SGLT2 inhibitors dapagliflozin pulmonary arterial hypertension
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.756226/full

Similar Items

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
by: Lin Huang, et al.
Published: (2022-06-01)

Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
by: Yi Tang, et al.
Published: (2022-04-01)

Denervation of pulmonary trunk and pulmonary orifice in patients with surgically corrected mitral valve disease against high pulmonary hypertension
by: N. A. Trofimov, et al.
Published: (2017-06-01)

Anomalous single pulmonary venous trunk
by: Hadi Abu Rasheed, et al.
Published: (2012-01-01)

Effects of dapagliflozin on congestion assessed by remote pulmonary artery pressure monitoring
by: Wilfried Mullens, et al.
Published: (2020-10-01)

Conditioned medium from M2b macrophages modulates the proliferation, migration, and apoptosis of pulmonary artery smooth muscle cells by deregulating the PI3K/Akt/FoxO3a pathway
by: Suiqing Huang, et al.
Published: (2020-05-01)

The prenatal development of aorta and pulmonary trunk valves.
by: Kozlovs’ka G.O.
Published: (2007-01-01)

Dapagliflozin reduces pulmonary vascular damage and susceptibility to atrial fibrillation in right heart disease
by: Chang Dai, et al.
Published: (2023-02-01)

Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling
by: Jinchun Wu, et al.
Published: (2022-09-01)

Evaluation of Pulmonary Hypertension in Dogs with Heartworm Disease Using the Computed Tomographic Pulmonary Trunk to Aorta Diameter Ratio
by: Jorge Isidoro Matos, et al.
Published: (2022-09-01)

Pulmonary sling in a patient with common arterial trunk
by: Mohamed Sobh, et al.
Published: (2021-01-01)

Hepatic Vessels Condition in Experimental Pulmonary Trunk Stenosis With Different Level of Blood Circulation Compensation
by: S.V. Kulikov
Published: (2009-06-01)

Clinical Evaluation of Dapagliflozin in the Management of CKD: Focus on Patient Selection and Clinical Perspectives
by: Nashar K, et al.
Published: (2022-11-01)

Tetralogy of Fallot with Absent Pulmonary Valve: A Single-center Experience
by: Biswajit Majumder, et al.
Published: (2024-06-01)

Chronic left pulmonary artery occlusion caused by a distal aortic arch aneurysm: Simultaneous Frozen Elephant Trunk and left sided pulmonary endarterectomy after livesaving TEVAR for aortic rupture
by: Anja Osswald, et al.
Published: (2024-03-01)

Transcatheter coil embolization of a complex pulmonary artery pseudoaneurysm with thyrocervical trunk-pulmonary arterial fistulization in a patient with cystic fibrosis and massive hemoptysis
by: Zachary T. Smith, BS, et al.
Published: (2022-06-01)

Management of Diabetes Associated with Nephrotic Syndrome: Therapeutic Potential of Dapagliflozin for Protracted Volume Retention
by: Toshimi Imai, et al.
Published: (2015-11-01)

Transection of the cervical sympathetic trunk inhibits the progression of pulmonary arterial hypertension via ERK-1/2 Signalling
by: Yongpeng Zhao, et al.
Published: (2019-06-01)

Intralobar Pulmonary Sequestration with Anomalous Artery Arising from the Celiac Trunk
by: Alexandr E. Mashkov, et al.
Published: (2021-02-01)

Primary pulmonary amebic abscess in a patient with pulmonary adenocarcinoma: a case report
by: Yuan-Yuan Liu, et al.
Published: (2018-04-01)

Comparison of Extraglycemic effects of Dapagliflozin and Empagliflozin
by: Haroon Aziz, et al.
Published: (2023-06-01)

Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin
by: Julio Rosenstock, et al.

CT Manifestations of Pulmonary Infarction Secondary to Acute Pulmonary Embolism
by: Haiping ZHANG, et al.
Published: (2022-04-01)

Benefit or Risk in Patient with Type 1 Diabetes Based on Appropriated Dosage of Dapagliflozin: A Case Report
by: Yan Tian, et al.
Published: (2023-04-01)

Sex-Dependent Changes in Right Ventricular Gene Expression in Response to Pressure Overload in a Rat Model of Pulmonary Trunk Banding
by: Hicham Labazi, et al.
Published: (2020-10-01)

Utility of Computed Tomographic Angiography for Pulmonary Hypertension Assessment in a Cohort of West Highland White Terriers With or Without Canine Idiopathic Pulmonary Fibrosis
by: Eugénie Soliveres, et al.
Published: (2021-09-01)

Safety assessment of dapagliflozin: Real-world adverse event analysis based on the FAERS database from 2012 to 2023
by: Zhengxi Zhou, et al.
Published: (2024-06-01)

Comparative Efficacy of Dapagliflozin and Empagliflozin of a Fixed Dose in Heart Failure: A Network Meta-Analysis
by: Zepeng Shi, et al.
Published: (2022-04-01)

Spatial relationship between the pulmonary trunk and the left coronaries: Systematic risk assessment based on automated three-dimensional distance measurementsKey Findings
by: Eberhard Scholz, MD, PhD, et al.
Published: (2020-04-01)

Evaluation of the Effect of COVID-19 on Pulmonary Artery and Aortic Diameter and the Relationship Between These Vessels and Lung Volume
by: Muhammet Değermenci, et al.
Published: (2023-12-01)

Dapagliflozin Does Not Protect against Adriamycin-Induced Kidney Injury in Mice
by: Jin Joo Cha, et al.
Published: (2024-01-01)

Pulmonary endarterectomy in patients with occlusive isolated pulmonary vasculitis
by: Jiexu Ma, et al.
Published: (2023-08-01)

Effect of Dapagliflozin in Patients with Heart Failure: A Systematic Review and Meta-Analysis
by: Ahmed E. Ali, et al.
Published: (2023-08-01)

Exercise mitigates Dapagliflozin-induced skeletal muscle atrophy in STZ-induced diabetic rats
by: Xudong Yang, et al.
Published: (2023-07-01)

Impact of dapagliflozin on life expectancy in type 2 diabetes mellitus patients in routine practice
by: M. B. Antsiferov, et al.
Published: (2023-08-01)

Dapagliflozin in peritoneal dialysis patients: a pilot study evaluating peritoneal membrane function
by: Zakaria Hamdan, et al.
Published: (2024-01-01)

The effects of dapagliflozin on serum electrolytes concentration in adult male rats
by: Muhsin S. G. Al-Mozie'l, et al.
Published: (2018-12-01)

Safety and efficacy of balloon pulmonary angioplasty for technically operable chronic thromboembolic pulmonary hypertension
by: Jinzhi Wang, et al.
Published: (2024-01-01)

Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA‐CKD Trial
by: Glenn M. Chertow, et al.
Published: (2023-05-01)

Angiosarcoma of the pulmonary artery mimicking pulmonary thromboembolism
by: Sitang Nirattisaikul, et al.
Published: (2021-08-01)